AJCP / Meeting AbstrActs PAX8 and NKX2.1, indicating absence of thyroid follicle lining cells. None of these parathyroid specimens manifest common somatic mutations seen in thyroid neoplasia. miR expression profiling, using criteria applied to thyroid follicular neoplasia, would have indicated thyroid malignancy if inappropriately assumed to be thyroid. Specific relative miR expression levels differentiated each of the parathyroid states. Normal parathyroid underexpressed miR138. PH underexpressed miR31, 204, and 551. PA overexpressed miR29b, 146, and 375. PC showed hyperexpression of miR31, 204, and 551. Conclusion: Parathyroid lesion can confound FNA cytology diagnosis of nodules presumed to be of thyroid origin. In this initial study ancillary molecular testing can affirm parathyroid tissue origin (messenger RNA expression) and miR expression profiling appears capable of differentiating between parathyroid disease states supporting further confirmatory studies. The approach is effective on fixative-treated specimens. Introduction: Hepatitis C virus (HCV) infection, estimated in 3% of the world's population, remains a major risk factor for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Based on the recognition of single-stranded viral RNA, TLR7 and TLR8 have been suggested to play important roles in antiviral immune responses to HCV. The miRNAs, endogenously expressed small noncoding RNAs, are known to promote mRNA degradation and block protein translation. In the present study, the specific candidate miRNAs that influence HCV protein-modulated TLR7/8 expression and subsequent signal modulation were investigated. Methods: miRNA microarray analysis was performed to screen for the miRNAs expression in HCV structure proteins (core, E1, and E2) stably transfected HepG 2 cells, and miRBase was used to predict the interaction between these miRNAs and TLR7/8 gene. miR-494-3p and miR942-3p were identified and validated. A total of 100 serum samples (30 samples from controls, 70 samples from HCV-infected patients) were collected. The levels of the two, miR-494-3p and miR942-3p, were then detected by probe-based stem-loop quantitative reverse-transcriptase PCR. Results: We found that the expression of serum miR-494-3p and miR942-3p was distinctly increased in HCV patients compared with controls (mean ± SEM: 917.7 ± 192.2 vs
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Conclusion:
The expression of miR-494-3p and miR942-3p in serum were significantly up-regulated in patients with HCV infection. However, the modulation mechanisms of miR494-3p and miR942-3p on TLR7/8 need further investigation.
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Several lineage-survival factors that operate during normal lineage development but become deregulated in the process of carcinogenesis were exploited as key oncogenic dependencies during tumor progression. However, this newly recognized mechanism of lineage addiction has not been studied in the context of high-grade serous ovarian cancers (HGSOCs). PAX8 is a lineage-defining transcription factor for Müllerian epithelia, which is expressed in both normal fallopian tube secretory epithelial cells (FTSECs) and their malignant counterpart, HGSOCs. Pax8 -/-female mice display infertility due to a functional defect in the development of the female reproductive tract. In addition, PAX8 is the single most differentially expressed gene when comparing ovarian cancer cell lines to all other cancer cell lines in the Cancer Cell Line Encyclopedia. Loss of PAX8 in ovarian cancer cell lines leads to apoptosis and decreased tumorigenicity, while cancer cell lines from other organ sites are unaffected. Here we hypothesize that PAX8 acquires different functions after malignant transformation and targeting the fallopian tube developmental program governed by PAX8 may serve as the basis for new ovarian cancer therapies. Using whole transcriptome shotgun sequencing (RNA-Seq) after PAX8 knockdown and ChIP-Seq, we show that FTSECs and HGSOCs are distinguished by marked reprogramming of the PAX8 cistrome. Genes that are significantly altered between FTSECs and HGSOCs are enriched near PAX8 binding sites. These sites are also near TEAD binding sites, and these transcriptional changes may be related to PAX8 interactions with the TEAD/YAP1 signaling pathway. These data suggest that transcriptional changes after transformation in ovarian cancer are closely related to epigenetic remodeling in lineage-specific transcription factors. Given the ubiquity of PAX8 expression on ovarian tumors, detailed examination of PAX8-associated cellular dependencies may reveal new aspects of the ovarian cancer pathogenesis and uncover selective vulnerabilities of tumor cells that will guide therapeutic approaches.
